Skip to content

Development of Dysphagia Protocol in Ankara City Hospital Stroke Patients

Development of Dysphagia Protocol in Ankara City Hospital Stroke Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04739514
Enrollment
55
Registered
2021-02-04
Start date
2021-02-01
Completion date
2021-06-30
Last updated
2021-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Acute

Brief summary

Stroke, also called cerebrovascular disease, is a sudden-onset neurological disorder that causes a regional or general dysfunction in the brain due to vascular causes. Dysphagia, one of the common complications of stroke, is associated with increased morbidity and mortality.The aim of this study is to evaluate the clinical evaluation of swallowing in stroke patients and to determine the factors affecting the severity and prognosis of dysphagia in patients with dysphagia.Fifty-five patients with acute stroke and dysphagia who were admitted to Ankara City Hospital Neurology Clinic and diagnosed with stroke by neurology and who did not meet the exclusion criteria will be included in this study. When the patients are admitted to the neurology clinic and will be discharged, they will be evaluated three times, in the first month after discharge.

Detailed description

Stroke, also called cerebrovascular disease, is a sudden-onset neurological disorder that causes a regional or general dysfunction in the brain due to vascular causes. Dysphagia, one of the common complications of stroke, is associated with increased morbidity and mortality.The aim of this study is to evaluate the clinical evaluation of swallowing in stroke patients and to determine the factors affecting the severity and prognosis of dysphagia in patients with dysphagia.Fifty-five patients with acute stroke and dysphagia who were admitted to Ankara City Hospital Neurology Clinic and diagnosed with stroke by neurology and who did not meet the exclusion criteria will be included in this study. When the patients are admitted to the neurology clinic and will be discharged, they will be evaluated three times, in the first month after discharge. Clinical evaluations will be made by the responsible investigator in the examination room. Patients will be evaluated with a bedside swallowing screening test. Patients will be divided into 3 groups as mild, moderate and severe dysphagia according to the test. The patients will be evaluated while they are in the neurology clinic and 1 month after the treatment is given.

Interventions

OTHERExercises for dysphagia rehabilitation

Diet modifications, postural exercises, compensatory exercises, swallowing exercises

Sponsors

Nazife Kapan
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with acute stroke by neurology * Having trouble swallowing * 18-85 years old, volunteers

Exclusion criteria

* Unconscious * Uncooperative * Those with oropharyngeal structural damage * Patients with malignancies involving the head and neck region

Design outcomes

Primary

MeasureTime frameDescription
Gugging swallowing screening testChange from Baseline Gugging swallowing screening test at 1 monthsThe gugging test is a validated test in the assessment of bedside swallowing. This test was defined as 20 points (no dysphagia), 15-19 (mild dysphagia), 10-14 (moderate dysphagia) and 9 points or less (severe dysphagia).
Eating assessment tool-10Change from Baseline Gugging swallowing screening test at 1 monthsThe eating assessment tool-10 is a test that evaluates dysphagia symptoms and severity without any food intake. This test is a test consisting of 10 questions in total and scoring the questions between no problem and serious problem. As the score increases, the severity of dysphagia increases.

Countries

Turkey (Türkiye)

Contacts

Primary ContactNazife K Kapan, Dr.
nazifekapan@gmail.com03125526000
Backup ContactMüyesser A Aras, Prof. Dr.
drmuyesser@hotmail.com03125526000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026